HistCite - Papers by K Fuxe

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1	1083 Fuxe K, Dahlstrom A, Hoistad M, Marcellino D, et al. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission BRAIN RESEARCH REVIEWS. 2007 AUG; 55 (1): 17-54	4	5	114	463
2	985 Agnati LF, Ferre S, Lluis C, Franco R, et al. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons PHARMACOLOGICAL REVIEWS. 2003 SEP; 55 (3): 509-550	47	124	97	425
3	1067 Fuxe K, Canals M, Torvinen M, Marcellino D, et al. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine JOURNAL OF NEURAL TRANSMISSION. 2007 JAN; 114 (1): 49-75	8	14	73	198
4	1094 Fuxe K, Marcellino D, Genedani S, Agnati L Adenosine A(2A) receptors, dopamine D-2 receptors and their interactions in Parkinson's disease MOVEMENT DISORDERS. 2007 OCT 31; 22 (14): 1990-2017	1	7	59	223
5	705 ZOLI M, AGNATI LF, HEDLUND PB, LI XM, et al. RECEPTOR-RECEPTOR INTERACTIONS AN INTEGRATIVE MECHANISM IN NERVE-CELLS MOLECULAR NEUROBIOLOGY. 1993 FAL-WIN; 7 (3-4): 293-334	37	54	47	274
6	1045 Fuxe K, Manger P, Genedani S, Agnati L The nigrostriatal DA pathway and Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2006; (70): 71-83	7	7	37	82
7	1091 Fuxe K, Ferre S, Genedani S, Franco R, et al. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function PHYSIOLOGY & BEHAVIOR. 2007 SEP 10; 92 (1-2): 210-217	0	6	37	55
8	1071 Diaz-Cabiale Z, Parrado C, Fuxe K, Agnati L, et al. Receptor-receptor interactions in central cardiovascular regulation. Focus on neuropeptide/alpha(2)-adrenoreceptor interactions in the nucleus tractus solitarius JOURNAL OF NEURAL TRANSMISSION. 2007 JAN; 114 (1): 115-125	0	1	34	65
9	274 FUXE K, HOKFELT T, OLSON L, UNGERSTEDT U CENTRAL MONOAMINERGIC PATHWAYS WITH EMPHASIS ON THEIR RELATION TO SO CALLED EXTRAPYRAMIDAL MOTOR SYSTEM PHARMACOLOGY & THERAPEUTICS PART B-GENERAL & SYSTEMATIC PHARMACOLOGY. 1977; 3 (2): 169-210	7	25	33	116
10	720 FUXE K, LI XM, BJELKE B, HEDLUND PB, et al. POSSIBLE MECHANISMS FOR THE POWERFUL ACTIONS OF NEUROPEPTIDES MODELS OF NEUROPEPTIDE ACTION. 1994; 739: 42-59	6	12	33	66
#	Date / Author / Journal	LCS	GCS	LCR	CR
11	873 Fuxe K, Ferre S, Zoli M, Agnati LF Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A(2A) dopamine D-2 and adenosine A(1) dopamine D-1 receptor interactions in the basal ganglia BRAIN RESEARCH REVIEWS. 1998 MAY; 26 (2-3): 258-273	22	126	33	75
12	1088 Agnati LF, Genedani S, Leo G, Rivera A, et al. One century of progress in neuroscience founded on Golgi and Cajal's outstanding experimental and theoretical contributions BRAIN RESEARCH REVIEWS. 2007 AUG; 55 (1): 167-189	1	1	32	111
13	437 FUXE K, AGNATI LF RECEPTOR-RECEPTOR INTERACTIONS IN THE CENTRAL NERVOUS-SYSTEM - A NEW INTEGRATIVE MECHANISM IN SYNAPSES MEDICINAL RESEARCH REVIEWS. 1985; 5 (4): 441-482	50	101	29	132
14	610 FUXE K, AGUIRRE JA, AGNATI LF, VONEULER G, et al. NEUROPEPTIDE-Y AND CENTRAL CARDIOVASCULAR REGULATION - FOCUS ON ITS ROLE AS A COTRANSMITTER IN CARDIOVASCULAR ADRENERGIC-NEURONS ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1990 NOV 15; 611: 111-132	14	31	29	64
15	1023 Agnati LF, Ferre S, Burioni R, Woods A, et al. Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases NEUROMOLECULAR MEDICINE. 2005; 7 (1-2): 61-78	4	9	29	128
16	686 AGNATI LF, FUXE K, BENFENATI F, VONEULER G, et al. INTRAMEMBRANE RECEPTOR RECEPTOR INTERACTIONS - INTEGRATION OF SIGNAL TRANSDUCTION PATHWAYS IN THE NERVOUS-SYSTEM NEUROCHEMISTRY INTERNATIONAL. 1993 MAR; 22 (3): 213-222	7	17	28	57
17	1020 Fuxe K, Ferre S, Canals M, Torvinen M, et al. Adenosine A(2A) and dopamine D-2 heteromeric receptor complexes and their function JOURNAL OF MOLECULAR NEUROSCIENCE. 2005; 26 (2-3): 209-219	7	26	28	57
18	835 Yang SN, Fior DR, Hansson AC, Cintra A, et al. Increased potency of neuropeptide Y to antagonize alpha(2)-adrenoceptor function in the nucleus tractus solitarii of the spontaneously hypertensive rat NEUROSCIENCE. 1997 JUN; 78 (3): 803-813	2	14	27	70
19	579 ZOLI M, ZINI I, AGNATI LF, GUIDOLIN D, et al. ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .1. COMPUTER-ASSISTED IMAGE-ANALYSIS METHODS NEUROCHEMISTRY INTERNATIONAL. 1990; 16 (4): 383-418	44	80	26	64
20	943 Fuxe K, Stromberg I, Popoli P, Rimondini-Giorgini R, et al. Adenosine receptors and Parkinson's disease - Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum PARKINSON'S DISEASE. 2001; 86: 345-353	10	25	24	40
#	Date / Author / Journal	LCS	GCS	LCR	CR
21	1093 Antonelli T, Fuxe K, Tomasini MC, Mazzoni E, et al. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain relevance for neurodegenerative diseases and their treatment PROGRESS IN NEUROBIOLOGY. 2007 OCT; 83 (2): 92-109	1	2	24	151
22	235 HOKFELT T, JOHANSSON O, FUXE K, GOLDSTEIN M, et al. IMMUNOHISTOCHEMICAL STUDIES ON LOCALIZATION AND DISTRIBUTION OF MONOAMINE NEURON SYSTEMS IN RAT-BRAIN .1. TYROSINE-HYDROXYLASE IN MESENCEPHALON AND DIENCEPHALON MEDICAL BIOLOGY. 1976; 54 (6): 427-&	16	313	23	86
23	530 HARFSTRAND A, FUXE K, AGNATI L, FREDHOLM B RECIPROCAL INTERACTIONS BETWEEN ALPHA-2-ADRENOCEPTOR AGONIST AND NEUROPEPTIDE-Y BINDING-SITES IN THE NUCLEUS TRACTUS SOLITARIUS OF THE RAT - A BIOCHEMICAL AND AUTORADIOGRAPHIC ANALYSIS JOURNAL OF NEURAL TRANSMISSION. 1989; 75 (2): 83-99	14	39	22	89
24	605 AGNATI LF, FUXE K NIGROSTRIATAL DOPAMINE NEURONS, D1 TRANSMISSION IN BASAL AND ISCHEMIC STATES AND PROTECTIVE EFFECTS OF GANGLIOSIDES LABORATORY INVESTIGATION. 1990 SEP; 63 (3): 283-297	2	5	22	64
25	1086 Guidolin D, Fuxe K, Neri G, Nussdorfer GG, et al. On the role of receptor-receptor interactions and volume transmission in learning and memory BRAIN RESEARCH REVIEWS. 2007 AUG; 55 (1): 119-133	1	2	22	124
26	1087 Ferraro L, Tomasini MC, Fuxe K, Agnati LF, et al. Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides BRAIN RESEARCH REVIEWS. 2007 AUG; 55 (1): 144-154	0	0	22	128
27	1114 Limacher A, Bhagwandin A, Fuxe K, Manger PR Nuclear organization and morphology of cholinergic, putative catecholaminergic and serotonergic neurons in the brain of the Cape porcupine (Hystrix africaeatistralis): Increased brain size does not lead to increased organizational complexity JOURNAL OF CHEMICAL NEUROANATOMY. 2008 SEP; 36 (1): 33-52	0	0	22	115
28	156 BOLME P, LIDBRINK P, FUXE K FUNCTION OF CENTRAL CATECHOLAMINE NEURONS - THEIR ROLE IN CARDIOVASCULAR AND AROUSAL MECHANISMS RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY. 1972; 4 (3): 657-&	5	59	21	120
29	390 AGNATI LF, FUXE K COMPUTER-ASSISTED MORPHOMETRY AND MICRODENSITOMETRY OF TRANSMITTER-IDENTIFIED NEURONS WITH SPECIAL REFERENCE TO THE MESOSTRIATAL DOPAMINE PATHWAY ACTA PHYSIOLOGICA SCANDINAVICA. 1984; : 5-66	0	0	21	109
30	748 CINTRA A, ZOLI M, ROSEN L, AGNATI LF, et al. MAPPING AND COMPUTER-ASSISTED MORPHOMETRY AND MICRODENSITOMETRY OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVE NEURONS AND GLIAL-CELLS IN THE RAT CENTRAL-NERVOUS-SYSTEM NEUROSCIENCE. 1994 OCT; 62 (3): 843-897	8	102	21	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
31	1057 Diaz-Cabiale Z, Parrado C, Rivera A, de la Calle A, et al. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPYY1 receptor subtype EUROPEAN JOURNAL OF NEUROSCIENCE. 2006 JUL; 24 (2): 499-508	1	3	21	42
32	455 FUXE K, AGNATI LF, HARFSTRAND A, JANSON AM, et al. MORPHOFUNCTIONAL STUDIES ON THE NEUROPEPTIDE-Y ADRENALINE COSTORING TERMINAL SYSTEMS IN THE DORSAL CARDIOVASCULAR REGION OF THE MEDULLA-OBLONGATA - FOCUS ON RECEPTOR-RECEPTOR INTERACTIONS IN COTRANSMISSION PROGRESS IN BRAIN RESEARCH. 1986; 68: 303-320	29	51	20	46
33	540 FUXE K, ANDERSSON K, ENEROTH P, HARFSTRAND A, et al. NEURO-ENDOCRINE ACTIONS OF NICOTINE AND OF EXPOSURE TO CIGARETTE-SMOKE - MEDICAL IMPLICATIONS PSYCHONEUROENDOCRINOLOGY. 1989; 14 (1-2): 19-41	3	84	20	146
34	591 FUXE K, AGNATI LF, HARFSTRAND A, ZOLI M, et al. ON THE ROLE OF NEUROPEPTIDE Y IN INFORMATION HANDLING IN THE CENTRAL-NERVOUS-SYSTEM IN NORMAL AND PHYSIOPATHOLOGICAL STATES - FOCUS ON VOLUME TRANSMISSION AND NEUROPEPTIDE Y DELTA-2 RECEPTOR INTERACTIONS ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1990 FEB 28; 579: 28-67	7	26	20	76
35	1084 Ferre S, Agnati LF, Ciruela F, Lluis C, et al. Neurotransmitter receptor heteromers and their integrative role in 'local modules': The striatal spine module BRAIN RESEARCH REVIEWS. 2007 AUG; 55 (1): 55-67	1	9	20	118
36	282 FUXE K, LOFSTROM A, HOKFELT T, FERLAND L, et al. INFLUENCE OF CENTRAL CATECHOLAMINES ON LHRH-CONTAINING PATHWAYS CLINICS IN OBSTETRICS AND GYNAECOLOGY. 1978; 5 (2): 251-269	3	23	19	82
37	452 FUXE K, AGNATI LF, HARFSTRAND A, ANDERSSON K, et al. STUDIES ON PEPTIDE COMODULATOR TRANSMISSION - NEW PERSPECTIVE ON THE TREATMENT OF DISORDERS OF THE CENTRAL-NERVOUS-SYSTEM PROGRESS IN BRAIN RESEARCH. 1986; 66: 341-368	4	4	19	69
38	703 ZOLI M, AGNATI LF, TINNER B, STEINBUSCH HWM, et al. DISTRIBUTION OF DOPAMINE-IMMUNOREACTIVE NEURONS AND THEIR RELATIONSHIPS TO TRANSMITTER AND HYPOTHALAMIC HORMONE-IMMUNOREACTIVE NEURONAL SYSTEMS IN THE RAT MEDIOBASAL HYPOTHALAMUS - A MORPHOMETRIC AND MICRODENSITOMETRIC ANALYSIS JOURNAL OF CHEMICAL NEUROANATOMY. 1993 SEP-OCT; 6 (5): 293-310	0	28	19	63
39	718 CINTRA A, BHATNAGAR M, CHADI G, TINNER B, et al. GLIAL AND NEURONAL GLUCOCORTICOID RECEPTOR IMMUNOREACTIVE CELL-POPULATIONS IN DEVELOPING, ADULT, AND AGING BRAIN BRAIN CORTICOSTEROID RECEPTORS. 1994; 746: 42-63	0	29	19	58
40	953 Ferre S, Popoli P, Gimenez-Llort L, Rimondini R, et al. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease PARKINSONISM & RELATED DISORDERS. 2001 JUL; 7 (3): 235-241	11	45	19	66
#	Date / Author / Journal	LCS	GCS	LCR	CR
41	1069 Franco R, Lluis C, Canela EI, Mallol J, et al. Receptor-receptor interactions involving adenosine A(1) or dopamine D-1 receptors and accessory proteins JOURNAL OF NEURAL TRANSMISSION. 2007 JAN; 114 (1): 93-104	0	3	19	76
42	1070 Antonelli T, Tomasini MC, Fuxe K, Agnati LF, et al. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D-2 interactions in the basal ganglia JOURNAL OF NEURAL TRANSMISSION. 2007 JAN; 114 (1): 105-113	1	1	19	52
43	526 VONEULER G, FUXE K, HANSSON T, OGREN SO, et al. EFFECTS OF CHRONIC TOLUENE EXPOSURE ON CENTRAL MONOAMINE AND PEPTIDE RECEPTORS AND THEIR INTERACTIONS IN THE ADULT MALE-RAT TOXICOLOGY. 1988 NOV 14; 52 (1-2): 103-126	7	24	17	51
44	542 HARFSTRAND A, CINTRA A, FUXE K, ARONSSON M, et al. REGIONAL DIFFERENCES IN GLUCOCORTICOID RECEPTOR IMMUNOREACTIVITY AMONG NEUROPEPTIDE-Y IMMUNOREACTIVE NEURONS OF THE RAT-BRAIN ACTA PHYSIOLOGICA SCANDINAVICA. 1989 JAN; 135 (1): 3-&	6	53	17	55
45	585 AGNATI LF, ZOLI M, PICH EM, BENFENATI F, et al. ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .7. THEORETICAL ASPECTS OF BRAIN COMMUNICATION AND COMPUTATION NEUROCHEMISTRY INTERNATIONAL. 1990; 16 (4): 479-500	21	22	17	137
46	656 FUXE K, AGNATI LF, VONEULER G, TANGANELLI S, et al. NEUROPEPTIDES, EXCITATORY AMINO-ACID AND ADENOSINE A2 RECEPTORS REGULATE D2 RECEPTORS VIA INTRAMEMBRANE RECEPTOR-RECEPTOR INTERACTIONS - RELEVANCE FOR PARKINSONS-DISEASE AND SCHIZOPHRENIA NEUROCHEMISTRY INTERNATIONAL. 1992 MAR; 20: S215-S224	4	9	17	62
47	699 BUNNEMANN B, FUXE K, GANTEN D THE RENIN-ANGIOTENSIN SYSTEM IN THE BRAIN - AN UPDATE 1993 REGULATORY PEPTIDES. 1993 JUL 23; 46 (3): 487-509	3	73	17	187
48	754 YANG SN, FIOR DR, HEDLUND PB, AGNATI LF, et al. ANTAGONISTIC REGULATION OF ALPHA(2)-ADRENOCEPTORS BY NEUROPEPTIDE-Y RECEPTOR SUBTYPES IN THE NUCLEUS-TRACTUS-SOLITARII EUROPEAN JOURNAL OF PHARMACOLOGY. 1994 DEC 12; 271 (1): 201-212	12	17	17	47
49	932 Belluardo N, Mudo G, Blum M, Fuxe K Central nicotinic receptors, neurotrophic factors and neuroprotection BEHAVIOURAL BRAIN RESEARCH. 2000 AUG; 113 (1-2): 21-34	6	71	17	171
50	1030 Torvinen M, Marcellino D, Canals M, Agnati LF, et al. Adenosine A(2A) receptor and dopamine D-3 receptor interactions: Evidence of functional A(2A)/D-3 heteromeric complexes MOLECULAR PHARMACOLOGY. 2005 FEB; 67 (2): 400-407	8	20	17	37

Date / Author / Journal

LCS

GCS

LCR

1083 Fuxe K, Dahlstrom A, Hoistad M, Marcellino D, et al.